Literature DB >> 25151024

Mechanism of action of anti-hypercholesterolemia drugs and their resistance.

Vishvanath Tiwari1, Manoj Khokhar2.   

Abstract

Coronary artery disease is one of the leading causes of death worldwide. One of the significant causes of this disease is hypercholesterolemia which is the result of various genetic alterations that are associated with the accumulation of specific classes of lipoprotein particles in plasma. A number of drugs are used to treat hypercholesterolemia like statin, fibrate, bile acid sequestrants, niacin, ezetimibe, omega-3 fatty acids and natural extracts. It has been observed that these drugs show diverse response in different individuals. The present review explains the mechanism of action of these drugs as well as mechanism of its lesser effectiveness or resistance in some individuals. There are various identified genetic variations that are associated with diversity in the drugs response. Therefore, present study helps to understand the ethiology of drug mechanism and resistance developed against drugs used to treat hypercholesterolemia.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-hypercholesterolemia drugs; Fibrate resistance; Hypercholesterolemia; Statin resistance

Mesh:

Substances:

Year:  2014        PMID: 25151024     DOI: 10.1016/j.ejphar.2014.07.048

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  15 in total

1.  Statin adjunctive therapy shortens the duration of TB treatment in mice.

Authors:  Noton K Dutta; Natalie Bruiners; Michael L Pinn; Matthew D Zimmerman; Brendan Prideaux; Véronique Dartois; Maria L Gennaro; Petros C Karakousis
Journal:  J Antimicrob Chemother       Date:  2016-02-21       Impact factor: 5.790

Review 2.  Effect of hypercholesterolaemia on myocardial function, ischaemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.

Authors:  Ioanna Andreadou; Efstathios K Iliodromitis; Antigone Lazou; Anikó Görbe; Zoltán Giricz; Rainer Schulz; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2017-02-08       Impact factor: 8.739

3.  New Perspectives for Fixed Dose Combinations of Poorly Water-Soluble Compounds: a Case Study with Ezetimibe and Lovastatin.

Authors:  Manoela K Riekes; Axel Engelen; Bernard Appeltans; Patrick Rombaut; Hellen K Stulzer; Guy Van den Mooter
Journal:  Pharm Res       Date:  2016-02-08       Impact factor: 4.200

4.  AGR2-induced cholesterol synthesis drives lovastatin resistance that is overcome by combination therapy with allicin.

Authors:  Nan Sheng; Yun-Qiu Wang; Cun-Fu Wang; Meng-Qi Jia; Huan-Min Niu; Qi-Qi Lu; Ya-Nan Wang; Dan Feng; Xiao-Xue Zheng; Hui-Qing Yuan
Journal:  Acta Pharmacol Sin       Date:  2022-04-22       Impact factor: 6.150

5.  A Modern Approach to Dyslipidemia.

Authors:  Amanda J Berberich; Robert A Hegele
Journal:  Endocr Rev       Date:  2022-07-13       Impact factor: 25.261

6.  Ezetimibe ameliorates atherogenic lipids profiles, insulin resistance and hepatocyte growth factor in obese patients with hypercholesterolemia.

Authors:  Hisashi Adachi; Hitoshi Nakano; Kiichiro Yamamoto; Masashi Nakata; Hisatoshi Bekki; Tomoki Honma; Hideki Yoshiyama; Masatoshi Nohara
Journal:  Lipids Health Dis       Date:  2015-01-10       Impact factor: 3.876

7.  Effects of an Enriched Extract of Paeoniflorin, a Monoterpene Glycoside used in Chinese Herbal Medicine, on Cholesterol Metabolism in a Hyperlipidemic Rat Model.

Authors:  Huiming Hu; Qiaoqiao Zhu; Jie Su; Yajun Wu; Yanchen Zhu; Yin Wang; Hui Fang; Minxia Pang; Bo Li; Suhong Chen; Guiyuan Lv
Journal:  Med Sci Monit       Date:  2017-07-14

8.  The Effects of Tocotrienol and Lovastatin Co-Supplementation on Bone Dynamic Histomorphometry and Bone Morphogenetic Protein-2 Expression in Rats with Estrogen Deficiency.

Authors:  Kok-Yong Chin; Saif Abdul-Majeed; Norazlina Mohamed; Soelaiman Ima-Nirwana
Journal:  Nutrients       Date:  2017-02-15       Impact factor: 5.717

9.  Treatment Strategy for Dyslipidemia in Cardiovascular Disease Prevention: Focus on Old and New Drugs.

Authors:  Donatella Zodda; Rosario Giammona; Silvia Schifilliti
Journal:  Pharmacy (Basel)       Date:  2018-01-21

10.  Antihypercholesterolemic Effects of Fruit Aqueous Extract of Copernicia prunifera (Miller) H. E. Moore in Mice Diet-Induced Hypercholesterolemia.

Authors:  Raquel Teixeira Terceiro Paim; Stephen Rathinaraj Benjamin; Davide Rondina; Márcia Maria Mendes Marques; Daniel de Araújo Viana; Maria Leônia da Costa Gonzaga; Ícaro Gusmão Pinto Vieira; Francisca Noélia Pereira Mendes; Paula Alves Salmito Rodrigues; Maria Izabel Florindo Guedes
Journal:  Evid Based Complement Alternat Med       Date:  2017-06-11       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.